We should some positive action on this soon. The needle should be close to the first target zone now. Given the oppies expiring marginally out of the money, the dilution will be minimal. Going by the companies own value of the top zone only, success there could be worth $1 per share (NPV) given the original guidance was given on 80m shares om issue. Now 40m or just above that.
Add to My Watchlist
What is My Watchlist?